Yayın:
Synthesis and evaluation of new benzimidazole derivatives with hydrazone moiety as anticancer agents

dc.contributor.authorULVİYE, ACAR
dc.contributor.authorÖzkay, Yusuf
dc.contributor.authorSAĞLIK ÖZKAN, BEGÜM NURPELİN
dc.contributor.authorArdıç, Cankız Mina
dc.contributor.authorAtlı, Özlem
dc.contributor.orcid0000-0003-1879-1034
dc.contributor.orcid0000-0002-0151-6266
dc.contributor.orcid0000-0001-8815-153X
dc.date.accessioned2025-11-13T09:42:14Z
dc.date.issued2018-03-01
dc.identifier.doihttps://doi.org/10.1515/tjb-2017-0167
dc.identifier.endpage158
dc.identifier.issn1303-829X
dc.identifier.issue2
dc.identifier.openalexW2795369611
dc.identifier.startpage151
dc.identifier.urihttps://hdl.handle.net/11421/1935
dc.identifier.urihttps://doi.org/10.1515/tjb-2017-0167
dc.identifier.volume43
dc.language.isoen
dc.relation.ispartofTurkish Journal of Biochemistry
dc.rightsopenAccess
dc.subjectChemistry
dc.subjectCytotoxicity
dc.subjectBenzimidazole
dc.subjectCisplatin
dc.subjectMoiety
dc.subjectStereochemistry
dc.subjectHydrazone
dc.subjectMTT assay
dc.subjectCombinatorial chemistry
dc.subjectIn vitro
dc.subjectBiochemistry
dc.subjectOrganic chemistry
dc.subjectChemotherapy
dc.subjectBiology
dc.subject.sdg3
dc.titleSynthesis and evaluation of new benzimidazole derivatives with hydrazone moiety as anticancer agents
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5047270177
local.authorid.openalexA5030511747
local.authorid.openalexA5074136342
local.authorid.openalexA5074836743
local.authorid.openalexA5110553744

Dosyalar

Koleksiyonlar